Early detection and biomarkers in pancreatic cancer.

  title={Early detection and biomarkers in pancreatic cancer.},
  author={David E. Misek and Tasneem H. Patwa and David M. Lubman and Diane M Simeone},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  volume={5 10},
Major advances in cancer control will be greatly aided by early detection for diagnosing and treating cancer in its preinvasive state before metastasis. Unfortunately, for pancreatic ductal adenocarcinoma (PDAC), which is the fourth leading cause of cancer-related death in the United States, effective early detection and screening are currently not available and tumors are typically diagnosed at a late stage, frequently after metastasis. Partly because of low sensitivity/specificity, existing… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 27 extracted citations

Pancreatic Cancer: What About Screening and Detection?

JOP : Journal of the pancreas • 2013
View 4 Excerpts
Highly Influenced

ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836.

Journal of controlled release : official journal of the Controlled Release Society • 2017
View 1 Excerpt

Evaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] • 2015
View 1 Excerpt

Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin.

Clinica chimica acta; international journal of clinical chemistry • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…